Studies Show Accutane Was Overprescribed, Adding To Bowel Disease Injuries And Accutane Lawsuits
Accutane is a potent drug. An acne medicine, it's been sold only thru prescription and administered in oral doses. Its active element, Isotretinoin, can reduce if not eliminate serious acne. But thanks to the drug's virility, Accutane shouldn't have been prescribed for anybody except those with dreadful acne problems.
Studies show this hasn't been the case. The highly advertised drug, available from 1982-2009, was prescribed for millions of patients, not just a troubled handful. Despite its virility, central authority studies show that, of those that received Accutane prescriptions, 90 per cent of girls and half teenagers didn't have harsh acne.
In other words, Accutane has been grossly overprescribed, leading to enormous profits for Roche Pharmaceuticals, a. K. A Hoffman-La Roche. The Swiss-based pharmaceutical giant's indifference to Americans' health is clear from its aggressive selling of a miscarried, defective drug, which was proved years back to cause serious wounds. These include inflammatory bowel disease (IBD) injuries known as ulcerative colitis and Crohn's illness.
Both are terrible. Why? First, they're lifelong and terminal. They can be dealt with, but cannot be eliminated. Victims must live with the effects of Roche's gluttony and dangerously assertive promoting for the remainder of their lives.
They can suffer cramping, stomach pain, soreness and abdominal bleeding. They may have to have stools suddenly and surprisingly during the day, making it tricky to maintain their occupation. They also may suffer such bowel trouble that they must have their colon removed, or part of their viscera removed.
These are serious and high-priced wounds, and Roche is answerable for them. The defective drug's manufacturer earned up to $1.2 bn. each year pushing its failed acne remedy, which it continued to do for years after it became clearer that the acne drug was causing serious injuries.
In effect admitting its disasters, Roche removed Accutane from the market in America in 2009 -- yet continues to sell it in other nations. Its American retreat could have been largely because of a increasing number of Accutane lawsuits and ensuing jury awards favoring victims. Indeed, in just a handful of American Accutane lawsuits to date, victims have been awarded a total of more than $56 million.
Though Accutane is not sold now in America, common Accutane is available in the form of Sotret, Amnesteem and Claravis. Each contains the harmful active constituent Isotretinoin, and each also could set off a devastating IBD injury to users. The national solicitor service of Accutane-Lawsuit-Lawyer.com stands ready to help all such Accutane victims with their Accutane lawsuit wishes. To find prompt legal help in your state, visit its website or call 1-800-339-0606.
Some patients might have consumed generic Accutane, which has been available since 2002. Generics include Sotret, Claravis and Amnesteem, all of which also contain Isotretinoin, which lowers oils released by glands and increases the body’s Vitamin A. Even though the U.S. Food and Drug Administration has already issued alerts about Accutane as well as calls it “potentially dangerous,” the drug is still sold in generic form. Roche extracted Accutane from the market in 2009.
Defective Drug Attorneys Can Aid In An Accutane Lawsuit